Skip to content
akaturk Academic measurement
Sign in Sign up

Article detail · 2018 · article

Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells

Journal Biomedicine and Pharmacotherapy
ISSN0753-3322
YÖKSİS OpenAlex Open access · bronze SJR Q1 JCR Q1
Year2018
Citations57OpenAlex
Percentile%88.0
FWCI2.111.00 = world average
Scopus (SJR)Q1
WoS (JCR)Q1
DOI10.1016/j.biopha.2018.04.020 OpenAlexOpenAlex record

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueBIOMEDICINE PHARMACOTHERAPY
  • Catalog match (ISSN)Biomedicine and Pharmacotherapy
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)

Abstract

Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

57citationsOpenAlex · cited_by_count (cache / database)

14 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2023 Therapeutic potential of hesperidin: Apoptosis induction in breast cancer cell linesCitations 18 · OpenAlex
  2. 2023 Therapeutic potential of hesperidin: Apoptosis induction in breast cancer cell linesCitations 18 · OpenAlex
  3. 2023 Therapeutic potential of hesperidin: Apoptosis induction in breast cancer cell linesCitations 18 · OpenAlex
  4. 2023 Therapeutic potential of hesperidin: Apoptosis induction in breast cancer cell linesCitations 18 · OpenAlex
  5. 2023 Therapeutic potential of hesperidin: Apoptosis induction in breast cancer cell linesCitations 18 · OpenAlex
  6. 2023 Therapeutic potential of hesperidin: Apoptosis induction in breast cancer cell linesCitations 18 · OpenAlex
  7. 2020 Flavonoids in cancer therapy: current and future trendsCitations 14 · OpenAlex
  8. 2025 Combined Hesperidin and Gemcitabine Therapy Modulates Apoptosis and Angiogenesis Pathways in ISHIKAWA Human Endometrial Adenocarcinoma CellsCitations 8 · OpenAlex
  9. 2025 Combined Hesperidin and Gemcitabine Therapy Modulates Apoptosis and Angiogenesis Pathways in ISHIKAWA Human Endometrial Adenocarcinoma CellsCitations 7 · OpenAlex
  10. 2025 Combined Hesperidin and Gemcitabine Therapy Modulates Apoptosis and Angiogenesis Pathways in ISHIKAWA Human Endometrial Adenocarcinoma CellsCitations 7 · OpenAlex

Authors

4
  1. ZEYNEP BİRSU ÇİNÇİN 1
  2. BAYRAM KIRAN 2
  3. YUSUF BARAN İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ 3
  4. BEDİA ÇAKMAKOĞLU İSTANBUL ÜNİVERSİTESİ 4